VERIFIED AGAINST INDEPENDENT SOURCES
We check every story against its sources before publishing — and we show the work. How we verify →
The Australian Institute of Health and Welfare's National Drug Strategy Household Survey shows daily smoking rates dropped to 5.6% last year, down from 8.3% two years ago. This national figure comes from a single large survey and has not been independently corroborated by other sources.
A national service in England has dispensed nearly 305,000 free doses of the morning-after pill through pharmacies between October 2025 and March 2026. This figure covers the first six months of the scheme and is approximate.
The FDA has approved Merck's first-in-class oral PCSK9 drug, Lipfendra, for high cholesterol on a national level. In six-month trials, the drug reduced LDL cholesterol by up to 60 percent. Its real-world impact is not yet known as the treatment is newly approved.
The PRIMA retinal implant has been approved for use in Europe. It restores functional central vision in people with geographic atrophy, improving vision to roughly 20/160, which is not full restoration. The approval is based on a small study.
The European Union has set a ban on BPA and other bisphenols in food packaging to take effect from July 2026, covering all 27 member states. The rules apply to food wrappers, containers, water bottles, lunch boxes and kitchenware. This is a forward-looking regulation, and any reduction in real-world BPA exposure has not yet been measured. The development comes from a single news report without independent corroboration provided here.
The FDA has approved enlicitide, sold as Lipfendra, as the first oral PCSK9 inhibitor for lowering blood cholesterol. The national approval gives patients a pill option in a drug class previously available only by injection. Its real-world impact will depend on insurance coverage and physician adoption, and actual effectiveness and adherence outside trials remain to be seen.
Researchers report that no women aged 20-24 in England died of cervical cancer between 2020 and 2024, which they describe as the first recorded five-year period with zero such deaths in this age cohort and attribute to high HPV vaccine uptake. The expected historical baseline is small, and this is an observational finding rather than a controlled causal demonstration. It has been reported by a single outlet citing a single research group, with no independent confirmation provided here.
The FDA approved Merck's Lipfendra nationwide for high-risk patients already taking statins. It is the first oral PCSK9 inhibitor. The approval is based on two studies and long-term data is limited to one year. Patients must take the medication on an empty stomach.
England and Wales have approved teplizumab for use on the NHS, making it available through the national health system to certain people at high risk of developing type 1 diabetes. The drug delays the onset of the disease by up to three years. It applies to a subset of at-risk individuals, not people already living with diabetes, and real-world rollout details and patient numbers have not yet been confirmed.
The drug Fampridine is now available on the NHS in England to help thousands of people with multiple sclerosis who have specific walking difficulties. About 40% of people who take the drug experience an improvement in walking speed. A trial period is required to confirm an individual patient will benefit, and the drug was already available in other UK nations.
India's Drug Controller General approved Takeda's QDENGA vaccine for people aged 4 to 60. This national authorization allows marketing across the country. The vaccine is not yet administered in India, and pricing or supply details are not yet determined.
A new study found that British Columbia's free take-home naloxone program prevented roughly 4 out of 5 potentially fatal overdoses during the province's toxic drug crisis. The 4 out of 5 figure is the study's modeled estimate, not a directly observed count. The finding comes from a single study reported by CBC and has not yet been independently corroborated.
Preliminary CDC figures put the US infant mortality rate at slightly under 5.4 deaths per 1,000 live births in 2025, down from 5.5 in 2024. Across the United States, that translates to roughly 19,350 infant deaths, about 700 fewer than the prior year. The data are provisional and may be revised, the source is a single wire report with an internal contradiction, and researchers say they cannot identify what drove the decline.
Ugandan health authorities have declared the end of the country's Ebola outbreak. The declaration follows a 42-day monitoring period with no new cases. This is a national declaration and does not address the ongoing outbreak in the neighboring Democratic Republic of the Congo.
Two programs from the Mid-West Toronto Ontario Health Team have connected 15,000 residents in that part of the city to a primary care doctor. The initiative aims to improve access to care and make the health system more equitable.
Uganda has discharged its last confirmed Ebola patient. This begins a national 42-day countdown to officially declare the end of the outbreak. The situation is not yet over, as the country must complete the countdown without new cases.
In the Jammu and Kashmir region, health workers report no human rabies deaths in three years despite over 200,000 dog bites. This regional trend is linked to the widespread use of post-exposure prophylaxis. The reports do not specify an exact timeframe and the link to vaccination is not experimentally proven.
Malawi began a national rollout of the injectable HIV prevention drug lenacapavir on July 2, 2026. This is an early-stage national rollout, and there is no data yet on its uptake or impact.
A brain-computer interface implant restored the sense of touch in one person with quadriplegia. The participant was able to feel his dog's fur. This was an early-stage clinical trial with a single participant, so generalizability to broader populations has not yet been demonstrated.
Participants in the Michigan Women, Infants, and Children program can now use their benefits to shop online for groceries at Meijer stores statewide. The program is a recent implementation and may not yet cover all WIC-eligible items or locations. This option is currently available only at Meijer.
A newly constructed 300-bed district hospital was inaugurated in Indore, Madhya Pradesh. This city/regional facility currently offers gynaecology and diagnostic services including MRI and CT scans. The hospital is partially operational at this time. The full operational status of all departments has not been specified.
Surgeons at NYU Langone Health transplanted both lungs and a liver from an HIV-positive donor into a 56-year-old HIV-positive recipient on March 21, 2026. This single patient, first-of-its-kind procedure was performed under a HOPE Act research protocol, which permits organ transfers between HIV-positive donors and recipients. The account comes from NYU Langone's own press release, reported by one outlet, with no independent corroboration yet and no long-term outcome data.
SRN Hospital in Prayagraj has started screening all blood units with NAT-ID technology. The service is provided free of charge to patients in the Prayagraj division. The screening was implemented this month and there is no long-term outcome data available yet. The information comes from hospital officials and has not been independently verified.